tirzepatide oral dosage Chart & Dosing Guide for Weight Loss Introducing Oral Tirzepatide: A Convenient

In the fall of 2024, Novo Nordisk wrapped up existing claims and settled with numerous generics, including Mylan, Dr

The booming GLP-1 market, projected to reach $167bn by 2031, presents compelling opportunities for private equity players to carve out their niche and capture substantial value, despite industry giants Novo Nordisk and Eli Lilly dominating the lions share of the market. Download PDF

The miracle weight loss drug, GLP-1, is helping the public to trim down but what does this mean for brands?

New research suggests that stopping GLP-1 drugs may raise risks of heart attack and stroke, complicating the booming weight loss trend.

The complete guide to traveling with GLP-1 medications semaglutide, tirzepatide, TSA rules, cooling cases, and the key differences that matter for travel.